標(biāo)題: Titlebook: Drug Design and Discovery; Inhibitors of Mitoge Surya K. De Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive lice [打印本頁(yè)] 作者: Hallucination 時(shí)間: 2025-3-21 18:03
書目名稱Drug Design and Discovery影響因子(影響力)
書目名稱Drug Design and Discovery影響因子(影響力)學(xué)科排名
書目名稱Drug Design and Discovery網(wǎng)絡(luò)公開(kāi)度
書目名稱Drug Design and Discovery網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Drug Design and Discovery被引頻次
書目名稱Drug Design and Discovery被引頻次學(xué)科排名
書目名稱Drug Design and Discovery年度引用
書目名稱Drug Design and Discovery年度引用學(xué)科排名
書目名稱Drug Design and Discovery讀者反饋
書目名稱Drug Design and Discovery讀者反饋學(xué)科排名
作者: 芭蕾舞女演員 時(shí)間: 2025-3-22 00:02 作者: 絆住 時(shí)間: 2025-3-22 00:38
Nathan B. Fountain,Fritz E. Dreifuss are in the market for the treatment of cancer and other diseases. Many research institutes discovered preclinical ATP-competitive inhibitors of MAP kinases using fragment-based drug design or optimization of their initial hit from high-throughput screening to improve in vitro potency only but lack 作者: 造反,叛亂 時(shí)間: 2025-3-22 07:30 作者: ELUDE 時(shí)間: 2025-3-22 11:28
Excursus I: Values and Human Rights, specific target protein and effectively disrupt the activity of the target protein, which involve disease processes such as cancer progression, inflammatory responses, or infectious diseases. The reaction mechanisms of some FDA-approved covalent inhibitors are depicted. The binding mode of covalent作者: condescend 時(shí)間: 2025-3-22 14:50
https://doi.org/10.1007/978-3-031-75682-5Protein Kinase Inhibitors; Drug Design; Drug Delivery; Mitogen-Activated Protein Kinase Inhibitors; Clin作者: condescend 時(shí)間: 2025-3-22 20:00 作者: 控制 時(shí)間: 2025-3-23 00:30 作者: 呼吸 時(shí)間: 2025-3-23 05:27 作者: 過(guò)度 時(shí)間: 2025-3-23 09:20 作者: 狂熱文化 時(shí)間: 2025-3-23 13:27
http://image.papertrans.cn/e/image/284830.jpg作者: GRAIN 時(shí)間: 2025-3-23 16:25 作者: prostate-gland 時(shí)間: 2025-3-23 21:53 作者: aquatic 時(shí)間: 2025-3-24 01:27 作者: bifurcate 時(shí)間: 2025-3-24 03:07 作者: Diluge 時(shí)間: 2025-3-24 10:34 作者: 完成才會(huì)征服 時(shí)間: 2025-3-24 11:46 作者: 移植 時(shí)間: 2025-3-24 18:35
Covalent Inhibitors of MAP Kinases, specific target protein and effectively disrupt the activity of the target protein, which involve disease processes such as cancer progression, inflammatory responses, or infectious diseases. The reaction mechanisms of some FDA-approved covalent inhibitors are depicted. The binding mode of covalent作者: Urea508 時(shí)間: 2025-3-24 19:53
biological roles of MAP kinases, ATP-competitive and non-competitive inhibitors, covalent inhibitors, and more. This book is intended for professors in academia, researchers in pharmaceutical and biotechnology sectors working on protein kinases, and graduate students in pharmacy/chemistry..978-3-031-75684-9978-3-031-75682-5作者: 燈泡 時(shí)間: 2025-3-25 00:31 作者: Glutinous 時(shí)間: 2025-3-25 06:05 作者: chlorosis 時(shí)間: 2025-3-25 07:48
ges in designing small molecule inhibitors of MAP kinases.Pr.This book covers the important role small molecules can play in the modulation of stress-activated protein kinase (SAPK), also called the mitogen-activated protein kinase (MAPK) pathway, and the potential this may offer in enabling the dev作者: 思考 時(shí)間: 2025-3-25 14:02
Molecular Theory and Chemical Bonds,er of upstream kinases. Biology of MAP kinases and their roles in different diseases are described here. Structure of MAPK 8, 9, 10, interaction with other kinases, and localization of MAP kinases are summarized.作者: Graduated 時(shí)間: 2025-3-25 17:07 作者: Decibel 時(shí)間: 2025-3-25 20:39 作者: 變色龍 時(shí)間: 2025-3-26 02:17 作者: biopsy 時(shí)間: 2025-3-26 07:55
Biological Roles of MAP Kinases,er of upstream kinases. Biology of MAP kinases and their roles in different diseases are described here. Structure of MAPK 8, 9, 10, interaction with other kinases, and localization of MAP kinases are summarized.作者: 厚臉皮 時(shí)間: 2025-3-26 08:50 作者: 反應(yīng) 時(shí)間: 2025-3-26 14:22
8樓作者: 遭受 時(shí)間: 2025-3-26 16:53
8樓作者: blackout 時(shí)間: 2025-3-26 23:39
9樓作者: MIR 時(shí)間: 2025-3-27 04:08
9樓作者: 蓋他為秘密 時(shí)間: 2025-3-27 07:39
9樓作者: Emg827 時(shí)間: 2025-3-27 09:53
9樓作者: hankering 時(shí)間: 2025-3-27 16:09
10樓作者: 慢跑 時(shí)間: 2025-3-27 20:00
10樓作者: 放氣 時(shí)間: 2025-3-28 01:32
10樓作者: Evacuate 時(shí)間: 2025-3-28 03:48
10樓
